التفاصيل البيبلوغرافية
| العنوان: |
The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. |
| المؤلفون: |
Ibrahim, Nasrien, Januzzi, James L |
| المصدر: |
Expert Review of Cardiovascular Therapy; Sep2015, Vol. 13 Issue 9, p1017-1030, 14p |
| مصطلحات موضوعية: |
HEART failure, NATRIURETIC peptides, BIOMARKERS, TROPONIN, DIAGNOSIS, PROGNOSIS |
| مستخلص: |
Heart failure (HF) is a complex disease process that is challenging to diagnose and manage. For more than 15 years, biomarkers have been used to diagnose and the guide the management of patients with this disease. The gold standard biomarkers for HF are B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP); both are used for diagnosis and prognosis. More recently, there has been an interest in use of BNP and NT-proBNP for HF management as well. Important aspects regarding production and clearance of BNP and NT-proBNP exist, which are vital for the clinician to understand. Beyond BNP or NT-proBNP, other newer biomarkers such as mid-regional pro-atrial natriuretic peptide, soluble ST2, highly sensitive troponin and renal biomarkers may add value for prognostication and possibly, patient management. In this article, the authors will discuss the established and evolving role of BNP and NT-proBNP in HF, along with consideration of select newer biomarkers in this setting. [ABSTRACT FROM AUTHOR] |
|
Copyright of Expert Review of Cardiovascular Therapy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
